Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2025-12-28 @ 2:08 AM
Study NCT ID:
NCT04888468
Status:
COMPLETED
Last Update Posted:
2022-03-18
First Post:
2021-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Sponsor:
Chongqing Precision Biotech Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-12
First Submit QC Date:
None
Study First Post Date:
2021-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-16
Last Update Post Date:
2022-03-18
Last Update Post Date Type:
ACTUAL